Dennis A. Ausiello, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 40,500 shares at $259.56 ($10.6M) on 2024-08-06, disclosed to the SEC on 2024-08-08.
Scheduled sale ($10.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $259.56 | 1,627 | $422K | 4.0% |
| 2 | $259.56 | 1,627 | $422K | 4.0% |
| 3 | $260.40 | 3,742 | $974K | 9.2% |
| 4 | $260.40 | 3,742 | $974K | 9.2% |
| 5 | $261.63 | 6,212 | $1.6M | 15.3% |
| 6 | $261.63 | 6,212 |
| $1.6M |
| 15.3% |
| 7 | $262.79 | 4,367 | $1.1M | 10.8% |
| 8 | $262.79 | 4,367 | $1.1M | 10.8% |
| 9 | $263.72 | 3,408 | $899K | 8.5% |
| 10 | $263.72 | 3,408 | $899K | 8.5% |
| 11 | $264.95 | 632 | $167K | 1.6% |
| 12 | $264.95 | 632 | $167K | 1.6% |
| 13 | $266.45 | 262 | $70K | 0.7% |
| 14 | $266.45 | 262 | $70K | 0.7% |
| Total | $262.00 avg | 40,500 | $10.6M | 100% |
| Filing → |
| ALNY | SELL | 2018-03-14 | $2.6M | — | Filing → |
| ALNY | SELL | 2017-11-03 | $2.6M | — | Filing → |
| ALNY | SELL | 2015-04-23 | $1.1M | — | Filing → |